FetusNCIt concept

https://www.cochrane.org/fr/CD014715/PREG_precision-de-lechographie-du-premier-et-du-deuxieme-trimestre-pour-lidentification-des-anomalies
2024
United Kingdom
review of literature
french abstract
Intervention Not Given for Kawasaki Disease
KIT Mutation Analysis Was Not Performed
Lymph Node Dissection Was Not Performed
Unemployed
Nitric Oxide Measurement
American College of Cardiology/American Heart Association Lesion Complexity Score A
NF1 Mutation Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
History of Medical Treatment Absent
Has No Sibling
Additional Surgery for New Tumor Event Absent
Tumor Reoccurrence Absent After Initial Treatment
First Trimester
Adjuvant Post-operative Immunological Therapy Was Not Administered
Accuracy
IDH Family Wildtype
asthenia
First Degree Family History Cancer Negative
Regional Anesthesia was not Administered
Choose
Drug Accumulation 1.2 to 1.99
International Prognostic Index Low Risk Group
Medication Not Taken
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
No History of Gestational Complication
Tumor Progression Absent After Initial Treatment
No History of Congenital Heart Disease
Pregnancy
Ultrasound Mode
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Additional Molecular Studies Were Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
NON Mouse
IV Anesthesia was not Administered
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
RET Rearrangement Analysis Was Not Performed
pregnancy trimester, first
Not Lost to Follow-Up
Patient was not Postmenopausal with no Prior Oophorectomy
Ultrasound
De-Identification
Chief Complaint was Not Witnessed
ERBB2 Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
New Tumor Event After Initial Treatment Absent
No History of Kawasaki Disease
Routine Cytogenetics Were not Completed
EGFR Gene Amplification Negative
fetus, nos
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Adjuvant Post-operative Radiation Therapy Was Not Administered
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
ultrasonography, nos
ALK Rearrangement Analysis Was Not Performed
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
pregnancy
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Minor Criteria for Rheumatic Heart Disease Not Present
defect, nos
Chemical/Occupational Exposure Absent
PTEN Gene Mutation Negative
Neither Case or Control Status
IDH Family Mutation Analysis Was Not Performed
No History of Myopathy
Cancer History Absent
No Response to Intervention for Kawasaki Disease
Low Risk
Evidence of Disease Absent after Completion of Therapy
Documentation Absent
fetal ultrasonography
Caffeine Not Routinely Consumed
Family History of Stomach Cancer Absent
pregnancy, high-risk
Therapeutic Ionizing Radiation to Head History Absent
MET Mutation Analysis Was Not Performed
Abnormality
EGFR Amplification Analysis Was Not Performed
ATRX Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Norway
pregnancy, nos
Chemotherapy Not Received
Other Preoperative IV Medications were not Administered
Analytical Procedure Precision
Regardless
First Degree Family History Thyroid Cancer Negative
No Known History of Illicit Drug Use
Patient was Not Previously Evaluated for Current Chief Complaint
Exposure as Collected Occurrence
SDH Complex Mutation Analysis Was Not Performed
Negation
No History of Neonatal Complication
Molecular Genetic Variation
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Preoperative IV Antiemetics were not Administered
Ultrasonogram
Fluorescence In Situ Hybridization Was Not Performed
Abnormal Indicator
ATRX Gene Mutation Negative
New Disease is not Multifocal
Selenium and Vitamin E Efficacy Trial
First Degree Family History of Primary Brain Tumor Negative
Fetus
Petal
Neither
Ultrasound Imaging
Adjuvant I-131 Therapy Negative
PDGFRA Mutation Analysis Was Not Performed
Preoperative IV Antacids were not Administered
Radiation History Negative
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
ultrasonography, prenatal
Intercurrent Illness is Absent at Onset of Chief Complaint
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Unspecified
History of Colorectal Cancer Negative
Any Metastatic Diagnosis Absent
1p/19q Deletion Analysis Was Not Performed
Chief Complaint Not Caused by Trauma
Another Form of Birth Control was not Used
No Known History of Alcohol Use
Hypertension Absent
Radiation Therapy Not Received
IPSS-R Risk Category Low
Local Anesthesia Agents were not Administered
Preoperative IV Sedation was Not Administered
EGFR Mutation Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
Paraneoplastic Syndrome is Not Present
Preoperative IV Opiates were not Administered
TP53 Mutation Analysis Was Not Performed
Nitric Oxide
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
MGMT Promoter Methylation Testing Was Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
BRAF Rearrangement Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Additional Immunohistochemistry Was Not Performed
Disease Risk Index Low Risk
NRAS Mutation Analysis Was Not Performed
No History of Rheumatic Fever
No History of Non-Cardiac Surgery
KRAS Mutation Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Regular Smokeless Tobacco Use for Six Weeks or More Negative
risk
Analytical Procedure Accuracy
Physician Diagnosed Diabetes Absent
10q23/PTEN Locus Deletion Analysis Was Not Performed
BRAF Mutation Analysis Was Not Performed
Additional Surgery for New Metastatic Tumor Event Was Not Performed

---
https://www.rp2s.fr/wp-content/uploads/2024_SulfateMagnesium.pdf
2024
France
guideline
fetus
Magnesium Sulfate
Obstetrics
fetus, nos
indication of
indicators and reagents
suggestive of
magnesium sulfate
Fetus
Petal
magnesium sulfate

---
https://cngof.fr/app/pdf/RPC//ECHOGRAPHIE/CNEOF-Rapport 2023.pdf
2023
France
technical report
guideline
fetus
health planning guidelines
ultrasonography, prenatal
ultrasonography, nos
Fetus
Ultrasound Mode
fetal ultrasonography
Obstetrics
Lecture
Exposure as Collected Occurrence
Ultrasound
fetus, nos
Ultrasonogram
research report
Ultrasound Imaging
Regulatory Report
congresses as topic
Petal
albumin/globulin ratio
Ratio
Conference

---
https://www.reseau-naissance.fr/medias/2023/11/RSN-PRO_003-Reperage-des-consommations-dalcool-pendant-la-grossesse-accompagnement-de-la-femme-enceinte-et-du-nouveau-ne.pdf
2023
France
guideline
Fetus
fetus
Petal
Ethanol Ablation Therapy
fetus, nos
Tracking
Spotting

---